The novel coronavirus infection (Corona 19) vaccine jointly developed by the US pharmaceutical company Pfizer-Germany Bioentech on the 29th (local time) by the European Medicines Agency (EMA) did not show any association with the recently reported death after vaccination, and a new side effect. It also said that it was not confirmed.
EMA said in the results of a safety evaluation first released after the Pfizer-Bioentech Corona 19 vaccination began in EU member states at the end of last month.
The EMA evaluated reported deaths following Pfizer-Bioentech vaccination, including deaths in senile seniors, adding that the data did not show any association with this vaccination and the cases did not raise safety concerns.
The EMA explained that it analyzed deaths after vaccination and considered other diseases and considered mortality at that age in the general public.
EMA said the safety data collected during the Pfizer-Bioentech vaccination process were consistent with the known safety profile of the vaccine, and that no new side effects were found.
In addition, with regard to reports suspected of serious allergic reactions, he added that no new aspects of known side effects were identified.
According to AFP, 33 of the 20,000 elderly nursing home residents who received the Pfizer-Bioentech vaccine in Norway recently died.
Similar cases have been reported in France, Denmark, Finland, Iceland, and Sweden, raising concerns.
/yunhap news
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution